/NUNZ

NUNZ Stock - Nunzia Pharmaceutical Company

Q: What is the analyst price target for NUNZ?

Analyst price target information is not currently available for NUNZ.

Q: What is NUNZ's market cap?

Market capitalization information is not currently available for NUNZ.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for NUNZ

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2017

FY2018

FY2019

FY2020

FY2021

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-5.34

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2021	FY2020	FY2019	FY2018	FY2017
Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Income	$-78,060,908	$-39,327	$-33,635	$-27,172	$-13,043
Net Income	$-78,064,632	$-101,016,327	$-33,635	$-18,576	$-13,043
Net Margin	N/A	N/A	N/A	N/A	N/A
EPS	$-0.26	$-0.35	$-0.00	$-0.00	$-0.00

Company Overview

Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders. It offers its products through wholesalers, as well as through its website nunziapharma.com. The company was formerly known as Arizona Gold and Onyx Mining Company and changed its name to Nunzia Pharmaceutical Company in February 2018. Nunzia Pharmaceutical Company was incorporated in 1986 and is based in Long Beach, California.

Visit Website

Frequently Asked Questions about NUNZ

What is NUNZ's current stock price?

Nunzia Pharmaceutical Company (NUNZ) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for NUNZ?

No analyst price targets are currently available for this stock.

What sector is Nunzia Pharmaceutical Company in?

Nunzia Pharmaceutical Company operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is NUNZ's market cap?

Nunzia Pharmaceutical Company has a market capitalization of $0.00 billion, making it a small-cap company.

Does NUNZ pay dividends?

No, Nunzia Pharmaceutical Company does not currently pay a dividend to shareholders.